Skip to content
MARKETS / NASDAQ / SSII
NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP

SS Innovations International, Inc. SSII

10 fiscal years on record · USD · FY2025 reported · SEC filings only
$42.5M
▲ 105.7% YoY
$-12.1M
$-22.2M
In brief

What this company does

The company employs engineering and research and development staff and currently has a research and development team of 81 employees to focus on delivering future innovations and sustaining improvements that advance its mission. As of the date of the Annual Report, the company had 483 employees, 204 of whom were engaged in manufacturing, 122 in marketing, sales, clinical support and field service, 81 in research and development, 22 in sourcing, 4 in quality control and 50 in administration. Most of the company's employees are based at its facility in Gurgaon, Delhi NCR, India.

Written from the business description in SS Innovations International, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 10 March 2026. Every sentence was checked against that document before publication.

Growth
USD 42.5M
Revenue, FY2025 · full 10-year series below
Revenue $M Net income $M
FY2025 · Revenue 42.5 · Net income -12.1
20M40M-8M-16M2016201720182019202020212022202320242025
Compound annual growth
+209.3%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−29 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -19.3% · Net -28.5%
-100%-200%-300%2016201720182019202020212022202320242025
ROE
FY2025 · ROE -46.9%
-100%-200%2016201720182019202020212022202320242025

Each USD of equity lost 47 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -22.2
-8M-16M2016201720182019202020212022202320242025
Net buybacks $ Dividends $
FY2021 · Dividends — · Net buybacks 13100.0
5000100002021

Total assetsUSD 74.2M
EquityUSD 38.2M
CashUSD 3.2M
Current ratio1.86×

Equity funds 51% of total assets.

The 10-year record
10 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019201820172016
Revenue $B0.00.00.00.0······
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0····−0.0·
Income tax $B0.0·········
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0······
EPS, diluted $−0.06−0.11−0.14−0.03−0.05−0.05−0.16−0.05−0.05−0.03
Dividend / sh $··········
Payout %··········
ROE %−46.9−115.5−245.1·······
Shares out B0.190.170.170.130.040.030.020.020.020.02

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 44 reconciliationsAUDITED

Reconciled in 10 of 19 fiscal years. 51 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated inFlorida
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2016

Share this section

Download image